[
    "{\"step_by_step_thinking\": \"Zanubrutinib is a BTK inhibitor, but it is not the first-generation one. The first-generation BTK inhibitor approved by the FDA was Ibrutinib, as stated in Document [31]. Zanubrutinib is a second-generation BTK inhibitor, as mentioned in Document [0] and Document [4].\", \"answer_choice\": \"B. no\"}"
]